Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125499 · ClinicalTrials.gov registry record
A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
A clinical trial of Mild to Moderate Knee OA, sponsored by OrthoTrophix.
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT03125499 is a study of Mild to Moderate Knee OA that has completed, run by OrthoTrophix. The registered enrollment target is 54 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03125499, a study of Mild to Moderate Knee OA, has completed, sponsored by OrthoTrophix.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the long-term changes in patellar cartilage thickness in TPX-100 versus placebo-treated knees in subjects who participated in Study TPX-100-1 or TPX-100-2.
Conditions Studied
Interventions
- OTHER Previous treated with TPX-100
Study Locations (1)
California
- Dr. Samy Metyas - Covina
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-07-27 |
| Est. Completion | 2018-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125499
The ClinicalTrials.gov registry entry for NCT03125499 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoTrophix, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild to Moderate Knee OA appearing as the primary indexed condition, and to 1 intervention - of which Previous treated with TPX-100 is the first listed.
NCT03125499 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03125499 about?
NCT03125499 is a clinical study titled "A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees". To evaluate the long-term changes in patellar cartilage thickness in TPX-100 versus placebo-treated knees in subjects who participated in Study TPX-100-1 or TPX-100-2.
What is the current status of trial NCT03125499?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-07-27. Estimated completion is 2018-03-01.
What conditions does trial NCT03125499 study?
This clinical trial studies the following conditions: Mild to Moderate Knee OA.
What interventions are being tested in trial NCT03125499?
The interventions under investigation include: Previous treated with TPX-100 (OTHER).
Who is sponsoring clinical trial NCT03125499?
This trial is sponsored by OrthoTrophix, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03125499 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.